Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future vaccines against emerging encephalitides.

R E Johnston1, N L Davis

  • 1Carolina Vaccine Institute, University of North Carolina, Chapel Hill, North Carolina 27599-7292, USA. robert_johnston@med.unc.edu

Archives of Virology. Supplementum
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Medical Mistrust and Its Impact on Patient Satisfaction in Pediatric Caregivers.

Journal of racial and ethnic health disparities·2024
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Impact of red blood cell transfusions on intestinal barrier function in preterm infants.

Journal of neonatal-perinatal medicine·2018
Same author

Post-discharge outcomes of failed car seat tolerance screens: A case-control and follow-up study.

Journal of neonatal-perinatal medicine·2018
Same author

Excipient exposure in very low birth weight preterm neonates.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Routine fecal occult blood testing does not predict necrotizing enterocolitis in very low birth weight neonates.

Journal of neonatal-perinatal medicine·2016
Same journal

Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies.

Archives of virology. Supplementum·2008
Same journal

Structural biology of old world and new world alphaviruses.

Archives of virology. Supplementum·2005
Same journal

Ehrlichia under our noses and no one notices.

Archives of virology. Supplementum·2005
Same journal

The spread of the H5N1 bird flu epidemic in Asia in 2004.

Archives of virology. Supplementum·2005
Same journal

Control of arbovirus diseases: is the vector the weak link?

Archives of virology. Supplementum·2005
Same journal

Host range, amplification and arboviral disease emergence.

Archives of virology. Supplementum·2005
See all related articles

This study explores advanced live attenuated vaccines for emerging encephalitides. It presents a novel mutation strategy to enhance safety and effectiveness, alongside a adaptable vaccine vector system.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Emerging encephalitides pose significant public health challenges.
  • Existing vaccine strategies vary from traditional methods to novel technological approaches.

Purpose of the Study:

  • To explore rationally selected live attenuated vaccines for emerging encephalitides.
  • To present a novel mutation strategy for enhanced vaccine safety and efficacy.
  • To describe an adaptable vaccine vector system for rapid response to emerging viral diseases.

Main Methods:

  • Rational selection of attenuating mutations in live vaccines.
  • Development of a paired lethal and resuscitating mutation strategy.
  • Description of a vaccine vector system adaptable to emerging viral threats.

Related Experiment Videos

Main Results:

  • Rationally selected mutations improve attenuation without compromising vaccine effectiveness.
  • The paired mutation strategy significantly reduces the risk of reversion to virulence.
  • A vaccine vector system is proposed for rapid adaptation against emerging viruses.

Conclusions:

  • Advanced live attenuated vaccines offer promising strategies for controlling emerging encephalitides.
  • Novel mutation selection and vector systems enhance vaccine safety, efficacy, and rapid deployment capabilities.